[Drug therapy of acromegaly using bromocriptine: results after a 1-year therapy]. 1976

G Benker, and W Zäh, and H Günnewig, and K Hackenberg, and U Werner, and D Reinwein

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004873 Ergolines A series of structurally-related alkaloids that contain the ergoline backbone structure. Ergoline
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000172 Acromegaly A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80) Inappropriate Growth Hormone Secretion Syndrome (Acromegaly),Somatotropin Hypersecretion Syndrome (Acromegaly),Inappropriate GH Secretion Syndrome (Acromegaly),Hypersecretion Syndrome, Somatotropin (Acromegaly),Hypersecretion Syndromes, Somatotropin (Acromegaly),Somatotropin Hypersecretion Syndromes (Acromegaly),Syndrome, Somatotropin Hypersecretion (Acromegaly),Syndromes, Somatotropin Hypersecretion (Acromegaly)
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

G Benker, and W Zäh, and H Günnewig, and K Hackenberg, and U Werner, and D Reinwein
July 1975, Deutsche medizinische Wochenschrift (1946),
G Benker, and W Zäh, and H Günnewig, and K Hackenberg, and U Werner, and D Reinwein
December 1975, Lancet (London, England),
G Benker, and W Zäh, and H Günnewig, and K Hackenberg, and U Werner, and D Reinwein
November 1975, The Journal of endocrinology,
G Benker, and W Zäh, and H Günnewig, and K Hackenberg, and U Werner, and D Reinwein
January 1978, Acta endocrinologica. Supplementum,
G Benker, and W Zäh, and H Günnewig, and K Hackenberg, and U Werner, and D Reinwein
January 1978, Acta endocrinologica. Supplementum,
G Benker, and W Zäh, and H Günnewig, and K Hackenberg, and U Werner, and D Reinwein
January 1976, Annales d'endocrinologie,
G Benker, and W Zäh, and H Günnewig, and K Hackenberg, and U Werner, and D Reinwein
October 1981, Acta endocrinologica,
G Benker, and W Zäh, and H Günnewig, and K Hackenberg, and U Werner, and D Reinwein
October 1981, The New England journal of medicine,
G Benker, and W Zäh, and H Günnewig, and K Hackenberg, and U Werner, and D Reinwein
October 1979, The New England journal of medicine,
G Benker, and W Zäh, and H Günnewig, and K Hackenberg, and U Werner, and D Reinwein
February 1975, British medical journal,
Copied contents to your clipboard!